[Effect of thiol compounds on the development of experimental amyloidosis].
D000686:Amyloidosis / Q000139:chemically induced* / Q000473:pathology; D000818:Animals; D001797:Blood Protein Electrophoresis; D002364:Caseins / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology*; D002642:Chick Embryo; D004591:Electrophoresis, Polyacrylamide Gel; D005978:Glutathione / Q000494:pharmacology*; D006168:Guinea Pigs; D007279:Injections, Subcutaneous; D008099:Liver / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009206:Myocardium / Q000473:pathology; D012007:Rectum / Q000473:pathology; D013154:Spleen / Q000473:pathology; D013438:Sulfhydryl Compounds / Q000097:blood / Q000494:pharmacology*; D013961:Thyroid Gland / Q000473:pathology; D013997:Time Factors
D002364:Caseins; D002614:Chelating Agents; D013438:Sulfhydryl Compounds; D005978:Glutathione
Vilianie tiolovykh seodineniĭ na razvitie éksperimental'nogo amiloidoza